Combination Bortezomib-containing Regimens in Newly Diagnosed Patients With t (4; 14) Positive Multiple Myeloma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00570180
Recruitment Status : Completed
First Posted : December 10, 2007
Last Update Posted : December 2, 2016
Princess Margaret Hospital, Canada
Ortho Biotech, Inc.
Information provided by (Responsible Party):
University Health Network, Toronto

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : September 2015
  Actual Study Completion Date : September 2016